X4 Pharmaceuticals, Inc. · NASDAQ:XFOR
Morgan Stanley reported a 10.20% stake in X4 Pharmaceuticals, Inc. (Schedule 13G/A)
Event Feb 28, 2026 · Filed Mar 6, 2026
Morgan Stanley reported a 10.20% stake in X4 Pharmaceuticals, Inc., 8,884,338 shares, as a passive investor on Feb 28, 2026. Filed Mar 6, 2026 (Schedule 13G/A).
- Stake
- 10.20%
- Shares
- 8,884,338
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Morgan Stanley | 10.20% | 8,884,338 |
| Morgan Stanley Investment Management Inc. | 10.20% | 8,884,304 |
| Inception Trust | 5.20% | 4,518,236 |
Source
Related
- X4 Pharmaceuticals, Inc.
- Morgan Stanley
- X4 Pharmaceuticals, Inc. shareholders
- Schedule 13G · Morgan Stanley · Feb 12, 2026
- Form 4 · Craig Adam R · Oct 19, 2026
- Schedule 13G/A · FMR LLC · Oct 7, 2026
- Form 4 · Kirske David · Oct 5, 2026
- Schedule 13G · Venrock Healthcare Capital Partners III, L.P. · Sep 21, 2026
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026